Silverback Therapeutics Appoints Vickie L. Capps to Board of Directors and Audit Committee Chair - businesswire.com -BoardProspects

Silverback Therapeutics Appoints Vickie L. Capps to Board of Directors and Audit Committee Chair

businesswire.com Jun 4 2020 BoardMoves

SEATTLE--(BUSINESS WIRE)--Silverback Therapeutics (“Silverback”), a biopharmaceutical company advancing a pipeline of therapies that are systemically delivered, but locally active, today announced the appointment of Vickie L. Capps as director and audit committee chair...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- NASDAQ OMX Reports Record Fourth Quarter 2013 Results also mentions Nasdaq
- Amazon's Board Diversity Push Could Destroy Traditional Retail also categorized in BoardMoves
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
- USA Technologies’ Board of Director Nominees Underscore Company’s Commitment to Excellence and Superior Performance also published in businesswire.com
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- Cloud Foundry Board Elects EMC CTO As Chair also categorized in BoardMoves
- Accomplished Lawyer Returns to Fulbright's Houston Office also published in businesswire.com
- Verastem directors buy $475K of stock, company set for potential pivotal trials also mentions Sanofi
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board also categorized in BoardMoves

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Partner Publications, Question of The Week, Sponsored Content
Quotes
1. Vickie has had a distinguished career in finance and executive leadership, and I was fortunate to have her guidance on the board of Synthorx.
Topics Mentioned